|
EDX Medical Group PLC - Cambridge, England-based developer of digital diagnostic products and services - Shares begin trading on AIM under the code EDX and are withdrawn from the Apex Segment of the Aquis Stock Exchange Growth Market. EDX announced its intent to move to AIM in April, when it applied under a ‘streamlined admission process’ called the ‘AIM Designated Market’ route intended for companies previously on Aquis. The company listed on the Access segment of the Aquis Growth Market back in 2021. It was renamed EDX Medical in 2022 as part of a reverse takeover by EDX Medical Ltd. It then moved to Apex segment in 2024, and because it has been listed there for more than 18 months, it is not required to publish an admission document before joining AIM. Current share price: 10.25 pence, closed down 4.7% in London on Wednesday Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
